Nereida Parra Gimenez

Prof. Dr. Nereida Parra Gimenez

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2019 in Journal of Parasitology Research
Verified
Journal Article
Open access
PDF file
NGNereida Parra Gimenez
Nereida Parra Gimenez
ARArmando Reyna-Bello
Armando Reyna-Bello
There are three trypanosoma species of veterinary importance in South America: (1) Trypanosoma evansi, the causative agent of derrengadera mechanically transmitted by bloodsucking insects such as tabanids, (2) Trypanosoma vivax, also mechanically transmitted by some dipteras hematophages as tabanids and/or Stomoxys, and (3) T. equiperdum, a tissue parasite adapted to sexual transmission and the causative agent of dourine, a distinctive disease that affects only Equidae. In order to evaluate the parasitological, hematological, and serological response of sheep infected with T. vivax, T. evansi, and T. equiperdum, four female sheep were experimentally infected with Venezuelan trypanosome field isolates: two T. evansi of differing virulences, one T. equiperdum; one T. vivax. Parasitemia and clinical parameters such as hematocrit, red blood cell count, hemoglobin, and body temperature were measured. T. evansi caused a chronic disease with undulant parasitemia alternating with some cryptic periods of at least 54 days, with no clinical signs. T. equiperdum, never described as infectious to ruminants, also caused a chronic disease with low undulant parasitemia. T. vivax caused an acute infection with severe anemia showing a drop of more than 70% of the hematocrit value, high fever, and rapid deterioration of physical condition, for 36 days of infection. Indirect ELISAs using crude extracts of the three species of trypanosomes as antigens were performed for detection of anti-trypanosome antibodies in sheep sera. Cross-reaction was observed between the three parasite species. These results show that sheep are susceptible to the three-trypanosome species and suggest they can act as a reservoir when sheep are raised and managed with other important livestock such as cattle, horses, buffalos, or goats. These findings are especially interesting for T. equiperdum, a species that has not been reported as infective to sheep.

21 July 2023 in Molecules
Verified
Journal Article
Open access
PDF file
AMAli Mijoba
Ali Mijoba
EFEsteban Fernandez-Moreira
Esteban Fernandez-Moreira
NGNereida Parra Gimenez
Nereida Parra Gimenez
SESandra Espinosa
Sandra Espinosa
ZMZuleyma Blanco Marquez
Zuleyma Blanco Marquez
Jaime CharrisJaime Charris
Jaime Charris
A series of benzocycloalkanone derivatives have been prepared and evaluated as antimalarial and antitrypanosomal agents. The compounds were obtained by direct coupling of preformed 4-substituted benzaldehyde and indanone or tetralone substitutes through aldol condensation of Claisen-Schmidt using sodium hydroxide as a catalyst in ethanol at room temperature. Although designed to inhibit the formation of β-hematin in vitro, only three compounds, 10, 11, and 12, showed activities greater than 50% (75.16%, 63.02%, and 56.17%, respectively). The results of the in vivo antimalarial evaluation show that 10, 11, and 12 reduced parasitemia marginally, and an insignificant increase in the days of survival of the mice was observed. As trypanocidals, all compounds showed marginal activity as inhibitors of the proliferation of T. cruzi epimastigotes, except compound 33, with an activity of 51.08 ± 3.4% compared to the activity shown by the reference compound benznidazole 59.99 ± 2.9%. The compounds appear to have little cytotoxic effect against VERO cells in vitro; this new class of Michael acceptor agents clearly warrants further investigation.

30 August 2024 in Molecules
Verified
Journal Article
Open access
PDF file
AMAli Mijoba
Ali Mijoba
NGNereida Parra Gimenez
Nereida Parra Gimenez
EFEsteban Fernandez-Moreira
Esteban Fernandez-Moreira
HPHegira Hegira Ramírez Padilla
Hegira Hegira Ramírez Padilla
XMXenón Serrano Martín
Xenón Serrano Martín
Jaime CharrisJaime Charris
Jaime Charris
The aim of this work was to obtain and evaluate, as antiprotozoals, new derivatives of benzoate imidazo-1,3,4-thiadiazole 18–23 based on the concepts of molecular repositioning and hybridization. In the design of these compounds, two important pharmacophoric subunits of the fexnidazole prototype were used: metronidazole was used as a repositioning molecule, p-aminobenzoic acid was incorporated as a bridge group, and 1,3,4-thiadiazole group was incorporated as a second pharmacophore, which at position 5 has an aromatic group with different substituents incorporated. The final six compounds were obtained through a five-step linear route with moderate to good yields. The biological results demonstrated the potential of this new class of compounds, since three of them 19–21 showed inhibitory activity on proliferation, in the order of 50%, in the in vitro assay against epimastigotes of T. cruzi (Strain Y sensitive to nifurtimox and benznidazole) and promastigotes of L. donovani, at a single concentration of 50 μM.

11 May 2024 in Antibodies
Verified
Journal Article
Open access
PDF file
ACAlejandro Enrique Cornejo
Alejandro Enrique Cornejo
CFChristopher Franco
Christopher Franco
MRMariajosé Rodriguez-Nuñez
Mariajosé Rodriguez-Nuñez
APAlexis Hipolito García Piñero
Alexis Hipolito García Piñero
IBInirida Amada Belisario
Inirida Amada Belisario
Flor H  PujolFlor H Pujol
Flor H Pujol
SARS-CoV-2 vaccines have contributed to attenuating the burden of the COVID-19 pandemic by promoting the development of effective immune responses, thus reducing the spread and severity of the pandemic. A clinical trial with the Sputnik-V vaccine was conducted in Venezuela from December 2020 to July 2021. The aim of this study was to explore the antibody reactivity of vaccinated individuals towards different regions of the spike protein (S). Neutralizing antibody (NAb) activity was assessed using a commercial surrogate assay, detecting NAbs against the receptor-binding domain (RBD), and a plaque reduction neutralization test. NAb levels were correlated with the reactivity of the antibodies to the spike regions over time. The presence of Abs against nucleoprotein was also determined to rule out the effect of exposure to the virus during the clinical trial in the serological response. A high serological reactivity was observed to S and specifically to S1 and the RBD. S2, although recognized with lower intensity by vaccinated individuals, was the subunit exhibiting the highest cross-reactivity in prepandemic sera. This study is in agreement with the high efficacy reported for the Sputnik V vaccine and shows that this vaccine is able to induce an immunity lasting for at least 180 days. The dissection of the Ab reactivity to different regions of S allowed us to identify the relevance of epitopes outside the RBD that are able to induce NAbs. This research may contribute to the understanding of vaccine immunity against SARS-CoV-2, which could contribute to the design of future vaccine strategies.

18 September 2024 in Viruses
Verified
Journal Article
Open access
PDF file
CFChristopher Franco
Christopher Franco
ACAlejandro Enrique Cornejo
Alejandro Enrique Cornejo
MRMariajosé Rodriguez-Nuñez
Mariajosé Rodriguez-Nuñez
APAlexis Hipolito García Piñero
Alexis Hipolito García Piñero
IBInirida Amada Belisario
Inirida Amada Belisario
Flor H  PujolFlor H Pujol
Flor H Pujol
The COVID-19 pandemic was characterized by the emergence and succession of SARS-CoV-2 variants able to evade the antibody response induced by natural infection and vaccination. To evaluate the IgG reactivity and neutralizing capacity of the serum of individuals vaccinated with Sputnik V (105 volunteers vaccinated) against different viral variants. IgG reactivity to the Spike protein (S) was evaluated by ELISA. A plaque reduction neutralization test was performed using different viral variant isolates. At 42 days post-vaccination, the frequency of recognition and reactivity to the S protein of the Omicron variant was lower compared to that of the other variants. In general, a higher average neutralization titer was seen against the ancestral variant compared to the variants, especially Omicron. However, some sera exhibited a higher neutralization titer to the Gamma variant compared to the ancestral variant, suggesting unapparent exposure during the clinical trial. Antibodies induced by Sputnik V can recognize, persist, and neutralize SARS-CoV-2 variants, with Omicron being the one that best evades this response. These results represent a unique report on the humoral response induced by a globally lesser-studied vaccine in terms of efficacy and immune escape, offering insights into developing vaccines targeting unknown coronaviruses.

21 March 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
ACAlejandro Enrique Cornejo
Alejandro Enrique Cornejo
CFChristopher Franco
Christopher Franco
MRMariajosé Rodriguez-Nuñez
Mariajosé Rodriguez-Nuñez
APAlexis Hipolito García Piñero
Alexis Hipolito García Piñero
IBInirida Belisario
Inirida Belisario
Flor H  PujolFlor H Pujol
Flor H Pujol
Keywords: COVID-19, SARS-CoV-2, Antibody, ELISA, Spike, S1, S2, RBD, epitopes, Neutralization